U.S. Insurers Wasted Millions on Ivermectin for Covid-19, Study Finds
Researchers analyzing insurance claims data estimate that U.S. insurers have paid tens of millions of dollars for ivermectin as a covid-19 treatment, despite little good evidence that ivermectin does anything to treat or prevent the viral illness. During a single week in August 2021, private and Medicare insurance...